Crossref
Low-dose Chemotherapy, in Addition to Impacting Breast Cancer Metastasis, Establishes Immunomodulation: A Preclinical Study
Journal of Oncology Research and Therapy · 16.03.2026 · 11 (1)
DOI: 10.29011/2574-710x.10335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oncology Research and Therapy, online erschienen am 16.03.2026.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Low-dose Chemotherapy, in Addition to Impacting Breast Cancer Metastasis, Establishes Immunomodulation: A Preclinical Study. Journal of Oncology Research and Therapy, 11(1). https://doi.org/10.29011/2574-710x.10335
Vancouver
Low-dose Chemotherapy, in Addition to Impacting Breast Cancer Metastasis, Establishes Immunomodulation: A Preclinical Study. Journal of Oncology Research and Therapy. 2026;11(1). doi:10.29011/2574-710x.10335
BibTeX
@article{euvimed2026,
title = {Low-dose Chemotherapy, in Addition to Impacting Breast Cancer Metastasis, Establishes Immunomodulation: A Preclinical Study},
journal = {Journal of Oncology Research and Therapy},
year = {2026},
volume = {11},
number = {1},
doi = {10.29011/2574-710x.10335}
}
EUVIMED